Analyzing the above data and the results of studies on the concentration of copeptin in patients with developed preeclampsia, an experiment was designed to compare the concentration of circulating copeptin in the blood of pregnant women in each trimester who developed pregnancy-induced hypertension and in those who without such complications. This evidence concerns the gene AVP and preeclampsia.